Skip to content

Menstrual Cycle Hormones and Eating Behavior

Effect of Menstrual Cycle Hormone Changes on Eating Behavior and Nutrient Metabolism

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01407692
Acronym
FL-84
Enrollment
24
Registered
2011-08-02
Start date
2011-03-31
Completion date
2012-12-31
Last updated
2017-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dietary Habits, Food Preference

Keywords

menstrual cycle, estrogen

Brief summary

The purpose of this study is to determine if the phase of the menstrual cycle (opposed versus unopposed estrogen phase) affects eating behavior, including types of foods preferred, wanting/desire for specific foods, and perception of hunger.

Detailed description

This is an observational study to investigate the effect of endogenous estrogen (E2) and progesterone (P4) levels on eating behavior and energy-yielding nutrient metabolism. Eating behavior will be assessed during a complete menstrual cycle during the first month of the study. Participants will track the follicular and luteal phases of their menstrual cycle using urinary leuteinizing hormone (LH) kits, they will record information about their food intake, eating behaviors, and appetite in their home environments, and they will complete two laboratory test days: one test day scheduled during their follicular phase, and one test day scheduled during their luteal phase.

Interventions

None listed

Sponsors

USDA, Western Human Nutrition Research Center
Lead SponsorFED

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Body Mass Index between 20-30 Kg/m2 * regular menstrual cycles * sedentary lifestyle (physical activity not more than 30 minutes per day three times a week)

Exclusion criteria

* Fasting blood sugar greater than 110 mg/dL * Systolic Blood Pressure greater than 140 mmHg * Diastolic Blood Pressure greater than 90 mmHg * Fasting triglycerides greater than 120 mg/dL * Documented or self-reported chronic disorders such as arthritis, or other inflammatory diseases * Women who are Post-menopausal or Peri-menopausal * Pre-menopausal women who are pregnant, uni/multiparous, taking oral contraceptives, or who have menstrual cycles lasting less than 20 days or greater than 45 days, polycystic ovary syndrome (PCOS), amenorrhea, eumenorrhoea, or polymenorrhoea.

Design outcomes

Primary

MeasureTime frameDescription
Eating behaviorAt follicular (day 11) and luteal (day 26) phase of menstrual cycleEating behavior, including types of foods preferred, wanting/desire for specific foods, and perception of hunger will be measured using four questionnaires; Eating inventory: to assess dietary restraint, Stanford Brief Physical Activity Questionnaire, Food craving questionnaire, Eating behavior and attitudes questionnaire

Secondary

MeasureTime frameDescription
LeptinAt follicular (day 11) and luteal (day 26) phase of menstrual cycleLeptin measured in serum to assess appetite
Insulin sensitivityAt follicular (day 11) and luteal (day 26) phase of menstrual cycleTo determine if the phase of the menstrual cycle affects insulin sensitivity, we will measure plasma insulin, glucose and non-esterified fatty acids (NEFA).
Serum lipid profile changesAt follicular (day 11) and luteal (day 26) phase of menstrual cycleBlood samples will be analyzed for lipids and lipoproteins, including apoproteins A1, B, C-II, C-III, and E.
Urinary c-peptideAt follicular (day 11) and luteal (day 26) phase of menstrual cycleThe level of urinary C-peptide and creatinine will be measured in a 24-hour urine collection.
Endocannabinoid profileAt follicular (day 11) and luteal (day 26) phase of menstrual cycleEndocannabinoid profile measured in serum to assess appetite
progesteroneAt follicular (day 11) and luteal (day 26) phase of menstrual cycleProgesterone measured in serum in relation to appetite variables
Dehydroepiandrosterone (DHEA)At follicular (day 11) and luteal (day 26) phase of menstrual cycleDehydroepiandrosterone measured in serum in relation to appetite variables
Sex Hormone Binding Globulin (SHBG)At follicular (day 11) and luteal (day 26) phase of menstrual cycleSHBG measured in serum in relation to appetite variables
EstradiolAt follicular (day 11) and luteal (day 26) phase of menstrual cycleEstradiol measured in serum in relation to appetite variables

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026